Guardian Capital Advisors LP Astrazeneca PLC Transaction History

Guardian Capital Advisors LP

$967 Million
Q3 2024

A detailed history of Guardian Capital Advisors LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Guardian Capital Advisors LP holds 48,642 shares of AZN stock, worth $3.14 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

48,642

Previous 46,662 4.24%

Holding current value

$3.14 Million

Previous $3.64 Million 4.15%

% of portfolio

0.39%

Previous 0.41%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$76.67 - $87.62 $151,806 - $173,487	1,980 Added 4.24%	48,642 $3.79 Million
Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $349,817 - $423,225	-5,236 Reduced 10.09%	46,662 $3.64 Million
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $264,259 - $301,238	-4,330 Reduced 7.7%	51,898 $3.52 Million
Q4 2023 Feb 08, 2024	SELL	$61.89 - $69.28 $145,750 - $163,154	-2,355 Reduced 4.02%	56,228 $3.79 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $414,780 - $458,593	-6,396 Reduced 9.84%	58,583 $3.97 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $497,409 - $539,388	-7,115 Reduced 9.87%	64,979 $4.65 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $144,613 - $163,964	-2,290 Reduced 3.08%	72,094 $5 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $61,528 - $79,949	-1,135 Reduced 1.5%	74,384 $5.04 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $81,120 - $207,697	-1,530 Reduced 1.99%	75,519 $4.16 Million
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $162,965 - $195,635	-2,750 Reduced 3.45%	77,049 $5.01 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $67,476 - $81,282	-1,211 Reduced 1.49%	79,799 $5.48 Million
Q4 2021 Feb 10, 2022	SELL	$54.02 - $63.83 $57,531 - $67,978	-1,065 Reduced 1.3%	81,010 $4.73 Million
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $100,008 - $109,422	-1,800 Reduced 2.15%	82,075 $4.97 Million
Q2 2021 Aug 17, 2021	SELL	$48.42 - $60.18 $60,282 - $74,924	-1,245 Reduced 1.46%	83,875 $5.1 Million
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $15,091 - $17,420	-320 Reduced 0.37%	85,120 $4.24 Million
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $16,496 - $19,726	-340 Reduced 0.4%	85,440 $4.33 Million
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $99,240 - $114,257	-1,870 Reduced 2.13%	85,780 $4.56 Million
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $71,977 - $92,367	-1,670 Reduced 1.87%	87,650 $3.43 Million
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $17,572 - $23,868	465 Added 0.52%	89,320 $2.75 Million
Q4 2019 Feb 13, 2020	SELL	$42.46 - $50.46 $55,198 - $65,598	-1,300 Reduced 1.44%	88,855 $4.46 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $39,718 - $45,015	-990 Reduced 1.09%	90,155 $3.83 Million
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $16,776 - $18,756	-450 Reduced 0.49%	91,145 $3.83 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $44,894 - $54,420	-1,265 Reduced 1.36%	91,595 $3.55 Million
Q4 2018 Feb 13, 2019	SELL	$36.86 - $41.49 $26,539 - $29,872	-720 Reduced 0.77%	92,860 $3.3 Million
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $25,027 - $28,598	-720 Reduced 0.76%	93,580 $3.58 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $126,452 - $135,603	-3,660 Reduced 3.74%	94,300 $3.46 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $185,950 - $206,593	-5,640 Reduced 5.44%	97,960 $3.56 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $3,369 - $3,651	105 Added 0.1%	103,600 $3.67 Million
Q3 2017 Nov 15, 2017	SELL	$28.96 - $34.0 $31,276 - $36,720	-1,080 Reduced 1.03%	103,495 $3.58 Million
Q2 2017 Aug 14, 2017	BUY	N/A	104,575	104,575 $3.39 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Capital Advisors LP with notifications on news.

Account

Guardian Capital Advisors LP Astrazeneca PLC Transaction History